Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Investigation

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI118084PMID 7615841PMCID PMC185177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung.

  1995cited by this paper
• Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung.

  1995cited by this paper
• Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs.

  1994cited by this paper
• Cloning and sequence analysis of the human beta 1-adrenergic receptor 5'-flanking promoter region.

  1993cited by this paper
• Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

  1993cited by this paper
• Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells.

  1993cited by this paper
• Differential down-regulation of pulmonary β1- and β2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline

  1993cited by this paper
• Regular inhaled salbutamol and airway responsiveness to allergen.

  1993cited by this paper
• Differential down-regulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline.

  1993cited by this paper
• Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs.

  1992cited by this paper
• Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.

  1992cited by this paper
• From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors.

  1992cited by this paper
• Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto‐oncogenes in normal human osteoblast‐like cells

  1992cited by this paper
• Beta 2-agonists and corticosteroids: new developments and controversies. Report of a meeting in November 1990.

  1992cited by this paper
• Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma

  1992cited by this paper
• Localization of beta 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography.

  1991cited by this paper
• Regular inhaled beta-agonist treatment in bronchial asthma.

  1990cited by this paper
• Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients.

  1990cited by this paper
• A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP.

  1990cited by this paper
• Differential regulation of beta 1- and beta 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation.

  1990cited by this paper
• Genetic regulation of beta 2-adrenergic receptors in 3T3-L1 fibroblasts.

  1989cited by this paper
• Agonist-induced Destabilization of β-Adrenergic Receptor mRNA: Attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors

  1989cited by this paper
• Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors.

  1989cited by this paper
• Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.

  1988cited by this paper
• Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA.

  1988cited by this paper
• Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids.

  1988cited by this paper
• Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor mRNA levels.

  1988cited by this paper
• Glucocorticoids modulate beta-adrenoceptor subtypes and adenylate cyclase in brown fat.

  1988cited by this paper
• Evidence that glucocorticoid response elements in the 5'-noncoding region of the hamster beta 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family.

  1987cited by this paper
• Cloning of the cDNA for the human beta 1-adrenergic receptor.

  1987cited by this paper
• Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.

  1985cited by this paper
• Regulation of beta-adrenergic receptors by steroid hormones.

  1984cited by this paper
• Regulation of β-Adrenergic Receptors by Steroid Hormones

  1984cited by this paper
• Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids.

  1982cited by this paper
• Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids.

  1981cited by this paper
• Effect of hydrocortisone on beta-adrenergic receptors in lung membranes.

  1979cited by this paper
• Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy.

  1978cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• GPRASP1 deletion in mice abrogates adverse side effects associated with chronic stimulation of Beta2-adrenoceptor.

  2025cites this paper
• Bronchodilator response as an independent predictor of severity in bronchiectasis

  2025cites this paper
• Update on the Role of β2AR and TRPV1 in Respiratory Diseases

  2024cites this paper
• Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction

  2024cites this paper
• Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study

  2024cites this paper
• Spinal motoneuron excitability is homeostatically-regulated through β-adrenergic neuromodulation in wild-type and presymptomatic SOD1 mice

  2024cites this paper
• Infections and spinal cord injury: Covid-19 and beyond

  2022cites this paper
• State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma

  2021cites this paper
• Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

  2019cites this paper
• Glucocorticoids and Airway Smooth Muscle: A Few More Answers, Still More Questions

  2019cites this paper
• Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

  2019cites this paper
• Immunomodulation in Pediatric Asthma

  2019cites this paper
• Impaired CD8 T cell antiviral immunity following acute spinal cord injury

  2018cites this paper
• Glucocorticoids: Immunity and Inflammation

  2018cites this paper
• Glucocorticoids and β2-agonists regulate the pathologic metabolism of hyaluronic acid in COPD.

  2018cites this paper
• Stem Cell-Based Therapies and Tissue Engineering of Trachea as Promising Therapeutic Methods in Mustard Gas Exposed Patients

  2018cites this paper
• Development of multi-cellular human lung models to study inflammatory mechanisms and cell-cell interactions

  2018cites this paper
• Japanese guidelines for adult asthma 2017.

  2017cites this paper
• The Effect of Glucocorticosteroids on Th2 cells

  2017cites this paper
• The Effect of Glucocorticosteroids on Th 2 cells

  2017cites this paper
• Glucocorticosteroids.

  2017cites this paper
• Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation

  2016cites this paper
• Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.

  2016cites this paper
• Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma

  2016cites this paper
• Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR

  2016cites this paper
• Superiority of Combined Phosphodiesterase PDE3/PDE4 Inhibition over PDE4 Inhibition Alone on Glucocorticoid- and Long-Acting β2-Adrenoceptor Agonist–Induced Gene Expression in Human Airway Epithelial Cells

  2015cites this paper
• Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke

  2015cites this paper
• Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.

  2015cites this paper
• The Clinical Pharmacology of Past, Present, and Future Glucocorticoids

  2015cites this paper
• Transcriptomic analysis of skeletal muscle from beef cattle exposed to illicit schedules containing dexamethasone: identification of new candidate biomarkers and their validation using samples from a field monitoring trial

  2015cites this paper
• Formoterol synergy with des-ciclesonide inhibits IL-4 expression in IgE/antigen-induced mast cells by inhibiting JNK activation.

  2015cites this paper
• Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke.

  2014cites this paper
• Evaluation of beta-blockers for the treatment of asthma and chronic obstructive pulmonary disease

  2014cites this paper
• Sympathetic hyperexcitation in obesity may be protective against pulmonary hypertension

  2014cites this paper
• Japanese Guideline for Adult Asthma 2014.

  2014cites this paper
• Lentivirus vector-mediated Rho guanine nucleotide dissociation inhibitor 2 overexpression induces beta-2 adrenergic receptor desensitization in airway smooth muscle cells.

  2013cites this paper
• The role of adrenergic signaling in breast cancer biology

  2013cites this paper
• Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.

  2013cites this paper
• How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?

  2013cites this paper
• Adrenal hormone deprivation affects macrophage catecholamine metabolism and β2‐adrenoceptor density, but not propranolol stimulation of tumour necrosis factor‐α production

  2013cites this paper
• Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

  2013cites this paper
• Chapter 6 – Airway Pharmacology

  2013cites this paper
• Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.

  2013cites this paper
• The effect of polymorphisms of beta2 adrenoceptors on response to long-acting beta2 agonists in Iranian asthmatic patients.

  2013cites this paper
• Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease

  2013cites this paper
• Mechanisms of Impaired b-Adrenoceptor-induced Airway Relaxation by Interleukin-1 b In Vivo in the Rat

  2013cites this paper
• Mechanisms elevating ORMDL3 expression in recurrent wheeze patients: role of Ets-1, p300 and CREB.

  2012cites this paper
• LABAs: Pharmacology, Mechanisms and Interaction with Anti‐Inflammatory Treatments

  2012cites this paper
• Maprotiline treatment differentially influences cardiac β-adrenoreceptors expression under normal and stress conditions

  2012cites this paper
• Ectopic Hormone-Secreting Pheochromocytoma: A Francophone Observational Study

  2012cites this paper
• Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.

  2012cites this paper
• Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

  2012cites this paper
• The Role of Glucocorticoid Receptor Nuclear Trafficking in Oxidative Stress induced Corticosteroid Insensitivity

  2012cites this paper
• Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.

  2012cites this paper
• Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials

  2012cites this paper
• Management of asthma in children with long QT syndrome.

  2012cites this paper
• Salmeterol/Fluticasone Propionate

  2012cites this paper
• Inhaled Salmeterol/Fluticasone Propionate

  2012cites this paper
• Glucocorticoids: Pharmacology and Mechanisms

  2012cites this paper
• Treating the Small Airways

  2012cites this paper
• Inhaled salmeterol/fluticasone propionate combination

  2012cites this paper
• Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma

  2012cites this paper
• Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease.

  2011cites this paper
• How Can 1 1 3 ? 2-Adrenergic and Glucocorticoid Receptor Agonist Synergism in Obstructive Airway Diseases

  2011cites this paper
• Toll-like Receptors in Airway Inflammation in vitro and in vivo

  2011cites this paper
• How Can 1 + 1 = 3? β2-Adrenergic and Glucocorticoid Receptor Agonist Synergism in Obstructive Airway Diseases

  2011cites this paper
• MicroRNA let-7 establishes expression of β2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation

  2011cites this paper
• The scientific basis and challenges of combination inhaled products

  2011cites this paper
• A Review of Salmeterol–Fluticasone Propionate in Combination: Its Use in the Treatment of Chronic Obstructive Pulmonary Disease

  2011cites this paper
• The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.

  2011cites this paper
• Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.

  2011cites this paper
• Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle.

  2011cites this paper
• Glucocorticosteroids: current and future directions

  2011cites this paper
• Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

  2011cites this paper
• Effect of Glucocorticoids on Bone ²2-Adrenergic Receptor Signaling in Osteoblasts Contributes to the Catabolic

  2011cites this paper
• Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD.

  2011cites this paper
• Casted-immobilization downregulates glucocorticoid receptor expression in rat slow-twitch soleus muscle.

  2011cites this paper
• Rosiglitazone reverses salbutamol‐induced β2‐adrenoceptor tolerance in airway smooth muscle

  2011influential citation
• Biochemical Basis of Asthma Therapy*

  2011cites this paper
• C4 Drugs for the treatment of airway disease

  2011cites this paper
• β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.

  2011cites this paper
• Japanese guideline for adult asthma.

  2011cites this paper
• Muscle Plasticity and β2-Adrenergic Receptors: Adaptive Responses of β2-Adrenergic Receptor Expression to Muscle Hypertrophy and Atrophy

  2011cites this paper
• The synergistic anti-asthmatic effects of glycyrrhizin and salbutamol

  2010cites this paper
• Adaptive effects of the β2-agonist clenbuterol on expression of β2-adrenoceptor mRNA in rat fast-twitch fiber-rich muscles

  2010cites this paper
• combination Therapy with Budesonide and Formoterol in single Inhaler of Asthma

  2010cites this paper
• Budesonide/formoterol combination in COPD: a US perspective

  2010cites this paper
• Inhaled Corticosteroids

  2010cites this paper
• [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].

  2010cites this paper
• Symptoms and aspects on eosinophil activity in allergic rhinitis

  2010cites this paper
• Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

  2010cites this paper
• Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.

  2010cites this paper
• Potential therapeutic targets for steroid-resistant asthma.

  2010cites this paper
• Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy

  2010cites this paper
• [Triple therapy in chronic obstructive pulmonary disease].

  2010cites this paper
• Signal Transduction Pathways Involved in Glucocorticoid Actions

  2010cites this paper
• Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma

  2010cites this paper
• The effect of serum, glucocorticoids, gender and gestational age on the inactivation, synthesis and secretion of surfactant phospholipids by cultured foetal rat type II pneumocytes

  2010cites this paper
• Desensitization of β‐adrenergic receptors in lung injury induced by 2‐chloroethyl ethyl sulfide, a mustard analog

  2009cites this paper
• Combination Therapy with Budesonide and Formoterol in Single Inhaler of Asthma

  2009cites this paper